Fingerprint
Dive into the research topics of 'A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I study of the safety and tolerability of VLX600, an Iron Chelator, in patients with refractory advanced solid tumors
Kabir Mody, Aaron S. Mansfield, Lalitha Vemireddy, Peter Nygren, Joachim Gulbo, Mitesh Borad
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations